Arkolith/Insider Trading/HEPA/Form 4

LoPriore Vincent S

Executive Chairman, Director, 10% OwnerHepion Pharmaceuticals, Inc. (HEPA) · full profile →Form 4 · filed Apr 27, 2026
Net Buying
Open-Market Buys
$250K
Open-Market Sells
$0
Net Open-Market Flow
$250K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2026Buy(P)5.0M$0.04$200K5.0M
Apr 21, 2026Buy(P)1.3M$0.04$50K6.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-019029) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML